Cargando…
Immunotherapy for acute leukemia
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505159/ https://www.ncbi.nlm.nih.gov/pubmed/26143183 |
| _version_ | 1782381553943314432 |
|---|---|
| author | Boyiadzis, Michael Whiteside, Theresa L Pavletic, Steven Z |
| author_facet | Boyiadzis, Michael Whiteside, Theresa L Pavletic, Steven Z |
| author_sort | Boyiadzis, Michael |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4505159 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Impact Journals LLC |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-45051592015-07-23 Immunotherapy for acute leukemia Boyiadzis, Michael Whiteside, Theresa L Pavletic, Steven Z Aging (Albany NY) Editorial Impact Journals LLC 2015-06-24 /pmc/articles/PMC4505159/ /pubmed/26143183 Text en Copyright: © 2015 Boyiadzis et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Boyiadzis, Michael Whiteside, Theresa L Pavletic, Steven Z Immunotherapy for acute leukemia |
| title | Immunotherapy for acute leukemia |
| title_full | Immunotherapy for acute leukemia |
| title_fullStr | Immunotherapy for acute leukemia |
| title_full_unstemmed | Immunotherapy for acute leukemia |
| title_short | Immunotherapy for acute leukemia |
| title_sort | immunotherapy for acute leukemia |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4505159/ https://www.ncbi.nlm.nih.gov/pubmed/26143183 |
| work_keys_str_mv | AT boyiadzismichael immunotherapyforacuteleukemia AT whitesidetheresal immunotherapyforacuteleukemia AT pavleticstevenz immunotherapyforacuteleukemia |